-
公开(公告)号:CA2129159C
公开(公告)日:2007-03-06
申请号:CA2129159
申请日:1994-07-29
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER , LANG HANS-JOCHEN , SCHWARK JAN-ROBERT , WEICHERT ANDREAS , SCHOLZ WOLFGANG , ALBUS UDO
IPC: C07D233/64 , A01N1/02 , A61K31/16 , A61K31/33 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61P1/16 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P11/00 , A61P13/02 , A61P13/08 , A61P13/12 , A61P15/00 , A61P25/28 , A61P35/00 , A61P43/00 , C07C279/22 , C07D207/333 , C07D207/337 , C07D213/30 , C07D213/58 , C07D215/14 , C07D217/16 , C07D231/12 , C07D233/54 , C07D233/58 , C07D239/26 , C07D263/32 , C07D277/30 , C07D307/54 , C07D333/24 , C07D521/00
Abstract: The invention relates to benzoylguanidines of the formula I (see Formula I) where R(1) is H, Hal, -NO2, -C.ident.N, -X o-(CH2)p-(CF2)q-CF3, R(5)-SO m, R(6)-CO-, R(6)R(7)N-CO- or R(6)R(7)N-SO2-, where X is oxygen, S or NR(14), m is zero. 1 or 2, o is zero or 1, p is zero, 1 or 2, q is zero, 1, 2. 3, 4, 5 or 6, R(5) and R(6) are alk(en)yl, -C n H2n-R(8) or CF3, n is zero, 1, 2, 3 or 4, R(8) is cycloalkyl or phenyl, where R(6) also has the meaning of H, R(7) is H or alkyl; R(2) is (see Formula II) R(11) is (C1-C9) -heteroaryl, Y is oxygen, -S- or NR(12)-, R(12) ie H or (C1-C4)- alkyl; R(3) is defined as R(1), or is alkyl or -X-R(13) where X is oxygen, S or NR(14), R(14) is H or (C1-C3)-alkyl, R(13) is H, (cyclo)alkyl or -C b H2b-R(15) where b is zero to 4 and R(15) is phenyl; R(4) is hydrogen, -OR(16), -NR(16)R(17) or C r B2r+1 where R(16) and R(17) independently are hydrogen or (C1-C3)-alkyl, r is 1 - 4 as well as pharmaceutically tolerated salts thereof. The compounds I are outstandingly suitable as anti-arrhythmic pharmaceuticals having a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris.
-
公开(公告)号:CA2111386C
公开(公告)日:2006-11-14
申请号:CA2111386
申请日:1993-12-14
Applicant: HOECHST AG
Inventor: LANG HANS-JOCHEN , KLEEMANN HEINZ-WERNER , SCHOLZ WOLFGANG , ALBUS UDO
IPC: A61K31/165 , C07D213/62 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4412 , A61K31/47 , A61K31/472 , A61P9/06 , A61P9/08 , A61P9/10 , C07C279/22 , C07C311/08 , C07C317/44 , C07C323/62 , C07D207/32 , C07D207/337 , C07D213/64 , C07D213/643 , C07D213/65 , C07D213/66 , C07D213/68 , C07D213/70 , C07D215/20 , C07D215/26 , C07D217/02 , C07D217/24 , C07D231/12 , C07D233/54 , C07D233/64 , C07D239/34 , C07D249/02 , C07D249/08 , C07D277/30 , C07D307/58 , C07D333/32 , C07D521/00
Abstract: Benzoylguanidines of the formula I are described (see formula I) The compounds are outstandingly suitable as antiarrhythmic pharmaceuticals with a cardioprotective component for the prophylaxis and treatment of infractions and for the treatment of angine pectoris, and they also preventively inhibit, or greatly reduce, the pathophysiological processes in the formation of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias.
-
公开(公告)号:CA2130703C
公开(公告)日:2006-11-07
申请号:CA2130703
申请日:1994-08-23
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT , ALBUS UDO , KLEEMANN HEINZ-WERNER , LANG HANS-JOCHEN , WEICHERT ANDREAS , CRAUSE PETER , SCHOLZ WOLFGANG
IPC: A61K31/155 , C07C279/22 , A61K31/16 , A61K31/185 , A61K31/395 , A61K49/00 , A61P9/00 , A61P9/10 , C07C277/08 , C07C279/20 , C07C311/37 , C07C311/59 , C07C315/04 , C07C317/32 , C07C317/44 , C07C323/44 , C07C323/65 , C07C323/67 , C07D207/327 , C07D207/337 , C07D211/14 , C07D213/70 , C07D215/20 , C07D215/54 , C07D231/12 , C07D233/60 , C07D233/61 , C07D233/64 , C07D295/10 , C07D295/155 , C07D521/00
Abstract: Diacyl-substituted guanidines of the formula I (see formula I) are described where X(1) and x(2) are (see formula II) T1 is zero, 1, 2, 3 or 4, R(A) and R(B) are hydrogen, Hal, CN, OR(106), (O)(cyclo)- (fluoro)alkyl, NR(107)R(108), phenyl or benzyl, or X(1) and x(2) are (see formula III) T2a and T2b are, independently of each other, zero, 1 or 2, where the double bond can be in the E or Z con- figuration; or X(1) and X(2) arm (see formula IV) as are the pharmaceutically tolerated salts thereof. They are outstandingly suitable for use as antiarrhythmic pharmaceuticals possessing a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris, in connection with which they also inhibit or strongly reduce, in a preventive manner, the pathophysiological processes associated with the genesis of ischemically induced damage, in particular associated with the elicitation of ischemically induced cardiac arrhythmias. On account of their protective effects against pathological hypoxic and ischemic situations, the compounds of the formula I according to the invention can, as a consequence of inhibiting the cellular Na+/H+ exchange mechanism, be used as pharmaceuticals for treating all acute or chronic damage elicited by ischemia, or diseases induced primarily or secondarily thereby.
-
公开(公告)号:PL189605B1
公开(公告)日:2005-08-31
申请号:PL32567098
申请日:1998-04-01
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS , BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , LANG HANS JOCHEN , SCHWARK JAN-ROBERT , ALBUS UDO , SCHOLZ WOLFGANG
IPC: A61K31/155 , A61K31/165 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/00 , A61P25/00 , A61P35/00 , C07C279/10 , C07C279/20 , C07C279/22
Abstract: Benzoyl-guanidines of formula (I) and their salts are new. One of R2,R3 = H; and the other = -C(OH)MeCH2OH, -CHMeCH2OH or -C(OH)(Me)2; and R4 = Me, OMe, Cl or CF3 (preferably Me).
-
公开(公告)号:PL185755B1
公开(公告)日:2003-07-31
申请号:PL31872497
申请日:1997-02-28
Applicant: HOECHST AG
Inventor: BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , ENGLERT HEINRICH CH , LANG HANS J , ALBUS UDO , LAL BANSI , GHATE ANIL V
IPC: C07D295/14 , A01N1/02 , A01N47/44 , A61K31/155 , A61K31/165 , A61K31/445 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , C07C271/22 , C07C279/20 , C07C279/22 , C07C303/40 , C07C311/19 , C07C315/04 , C07C317/50 , C07C319/20 , C07C323/62
Abstract: 1-Naphthoyl-guanidines (I) and their salts are new: R2-R8 = H; F; Cl; Br; I; CN; NO2; CF3; C2F5; or XaYbZ; X = O; S; or NR10, CR11R12, CO, CONR10, COO, SO; SO2, SO2NR10, OCO, NR10CO or NR10SO2 attached to the ring via the left hand atom; R10-R12 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; Y = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; R13 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-6C cycloalkyl; Z = H; 1-7C alkyl; 3-7C cycloalkyl; COR15; SO2R15; NR16R17; or is Ph or a C- or N-linked N-containing 1-9C heterocycle (each optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR21R22); a, b = 0 or 1; R15 = N=C(NH2)2; NR18R19; N(CH2)cNR18R19; or OR20; c = 2 or 3; R16 - R19 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R16+R17 or R18+R19 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NQ; Q = H; Me; benzyl; or p-Cl-Ph; R20 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R21, R22 = H; 1-4C alkyl; or 1-4C perfluoroalkyl; provided that when R4 = alkoxy, at least one of R2, R3 and R5-R8 is not H.
-
公开(公告)号:HRP970450B1
公开(公告)日:2003-02-28
申请号:HRP970450
申请日:1997-08-21
Applicant: HOECHST AG
Inventor: SCHWARK JAN-ROBERT , BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , LANG HANS-JOCHEN , WEICHERT ANDREAS , JANSEN HANS-WILLI , SCHOLZ WOLFGANG
IPC: C07D213/65 , A01N1/00 , A61K31/155 , A61K31/165 , A61K31/44 , A61K31/4406 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , A61P13/02 , A61P15/00 , A61P25/00 , A61P43/00 , C07C277/08 , C07C279/20 , C07C279/22
Abstract: Phenyl-substituted alkenyl-carboxylic acid guanidide compounds of formula (I) are new. T = a group (i); Ra = H, F, Cl, Br, I , CN, OH, OR6, 1-4C alkyl, Or-(CH2)aCbF2b+1, 3-8C cycloalkyl or NR7R8; r = 0 or 1; a = 0 - 4; b = 1 - 4; R6 = 1-4C alkyl, 1-4C perfluoroalkyl, 3-6C alkenyl, 3-8C cycloalkyl, phenyl or benzyl; where the phenyl nucleus is optionally substituted by 1 - 3 F, Cl, CF3, CH3, OCH3 or NR9R10 groups; R9, R10 = H, 1-4C alkyl or 1-4C perfluoroalkyl; R7, R8 = as for R6; or R7+R8 = (CH2)4 or (CH2)5, where one of the CH2 groups may be replaced by O, S, NH, N-CH3 or N-benzyl; Rb, Rc, Rd = as for Ra; x, y = 0 - 2; Rf = H, F, Cl, Br, I, CN, OR12, 1-8C alkyl, Op-(CH2)f-CgF2g+1, 3-8C cycloalkyl or 1-9C heteroaryl; p = 0 or 1; f = 0 - 4; g = 1 - 8; R12 = 1-8C alkyl, 1-4C perfluoroalkyl, 3-8C alkenyl, 3-8C cycloalkyl, phenyl or benzyl; where the phenyl nucleus may be substituted by 1 - 3 F, Cl, CF3, CH3, OCH3 or NR13R14 groups; R13, R14 = H, 1-4C alkyl or 1-4C perfluoroalkyl; Re = as for Rf; R1 = as for T, or is H, Ok-CmH2m+1, On-(CH2)p-CqF2q+1, F, Cl, Br, I, CN, CO-N=C(NH2)2, SOr1R17, SOr2-NR31R32, Ou-(CH2)v-C6H5, Ou2-(1-9C heteroaryl) (sic) or Su2-(1-9C heteroaryl) (sic); k, n = 0 or 1; m = 0-8; q = 1 - 8; p = 0-4; r1, r2 = 0 - 2; R31, R32 = H, 1-8C alkyl or 1-8C perfluoroalkyl, or R31+R32 = (CH2)4 or (CH2)5, where one of the CH2 groups may be replaced by O, S, NH, N-CH3 or N-benzyl; R17 = 1-8C alkyl; u, u2 = 0 or 1; v = 0- 4. The phenyl nucleus may be substituted by 1-3 F, Cl, CF3, CH3, OCH3, (CH2)w-NR21R22, NR18R19 or 1-9C heteroaryl groups ÄsicÜ. R18, R19, R21, R22 = 1-4C alkyl or 1-4C perfluoroalkyl; w = 1 - 4; The heterocycle of the 1-9C heteroaryl may be substituted by 1 - 3 F, Cl, CF3, CH3 or OCH3 groups. R2, R3, R4 and R5 = as for R1; or R1+R2 or R2+R3 = CH-CH=CH-CH, which is optionally substituted by 1 - 3 F, Cl, CF3, CH3, OCH3, (CH2)w2-NR24R25 or NR26R27; R24, R25, R26, R27 = H, 1-4C alkyl or 1-4C perfluoroalkyl; w2 = 1 - 4; provided that T is present 2-3 times in the molecule.
-
公开(公告)号:PL183906B1
公开(公告)日:2002-07-31
申请号:PL31427896
申请日:1996-05-16
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS , BRENDEL JOACHIM , KLEEMANN HEINZ-WERNER , LANG HANS J , SCHWARK JAN-ROBERT , SCHOLZ WOLFGANG , ALBUS UDO
IPC: A01N1/02 , A61K31/155 , A61K31/165 , A61K31/18 , A61K49/00 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P41/00 , C07C303/40 , C07C311/16 , C07C315/04 , C07C317/44 , C07C279/22
Abstract: Benzoyl-guanidine derivs. of formula (I) and their salts are new: R1 = R4-SOm, R5R6N-SO2-, -Op-(CH2)q-(CF2)r-CF3, -SR10, -OR10 or -CR10R11R12; m = 1-2; R4, R5 = 1-8C alkyl, 3-6C alkenyl, CF3 or -CnH2n-R7; n = 0-4; R6 = H or 1-4C alkyl; R7 = 3-8C cycloalkyl or Ph (opt. substd. with 1-3 substits. from F, Cl, CF3, Me, OMe and NR8R9; R8, R9 = H or 1-4C alkyl; R5 = H; or R5 + R6 = 4-5C methylene group (with opt. replacement of a CH2 by O, S, NH, NMe or N-benzyl; ; p = 0-1; q = 0-2; r = 0-3;R10, R11, R12 = H, 1-8C alkyl, CsH2s-(3-8C cycloalkyl) or an aromatic gp. chosen from pyridyl, pyrrolyl, quinolyl, isoquinolyl, imidazolyl or Ph (in which the aromatic system may be opt. 1-3 times substd. by F, Cl, CF3, Me, OMe, OH, NH2, NHMe or N(Me)2; s = 0-2; R2 = -(CH2)u-(CF2)t-CF3; t = 0-3; u = 0-1; R3 = H or as for R1.
-
公开(公告)号:HRP960221B1
公开(公告)日:2002-02-28
申请号:HRP960221
申请日:1996-05-15
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER , BRENDEL JOACHIM , SCHWARK JAN-ROBERT , WEICHERT ANDREAS , LANG HANS-JOCHEN , ALBUS UDO , SCHOLZ WOLFGANG
IPC: C07D215/20 , A61K9/06 , A61K9/10 , A61K31/155 , A61K31/17 , A61K31/175 , A61K31/18 , A61K31/27 , A61K31/275 , A61K31/44 , A61K31/4406 , A61K31/4418 , A61K31/47 , A61K31/475 , A61K35/00 , A61P1/16 , A61P3/08 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P13/02 , A61P15/00 , A61P35/00 , A61P43/00 , C07C279/10 , C07C279/24 , C07C317/22 , C07C317/32 , C07C317/46 , C07D213/30 , C07D215/14 , G01N33/574 , G01N33/94
Abstract: Phenylalkyl (oxy or amino) carbonylguanidine cpds. of formula (I) are new. R1-R3 = Y-Phe, Py, Q-Phe', Het, SR25, OR25, NR25R26, CR25R26R27, En-CvH2v-G-A-R51, H, F, Cl, Br, I, CN, T(CH2)h(ClF2l+1), SOlR31, CONR32R33, COR34, SO2NR45R46, CF2R64, CFR65R66, CFÄ(CF2)qCF3ÜR65, CÄ(CF2)pCF3Ü=CR65R66, OR67, NR67R68, 1-8C alkyl, 2-8C alkenyl or (CH2)mR14; Phe = phenyl, (substd. by one R8 gp. and opt. substd. by 1 or 2 of R'); R' = F, Cl, CF3, Me, OH, OMe or NR15R16; Het = 1-9 heteroaryl, bonded by C or N (opt. substd. by 1-3 or R'); R15, R16, R56 = H or Me; Y = bond, CH2, O, S or NR9; R8 = SOa(NR98)bNR99R10 or SOa(NR98)bNR95-C(=NR94)NR92R93; a = 1 or 2; b = 0 or 1; a+b = 2; R10, R98, R99 = H, Me, benzyl, 2-8C alkyl (opt. substd. by NR11R12 or NR13-A'-NR37R38) or 0-8 alkyl (substd. by CR39R40-CR41R42A"NR43R44); or R99+R10 = 4-6C n-alkylene (opt. with one CH2 replace by O, S, NH, NMe or N-benzyl); A' = 2-8C alkylene; A" = 0-8C alkylene; R11-R13, R23, R24 R37, R38, R43, R44 = H, 1-8C alkyl or benzyl; R39-R42 = H, 4-8C alkyl, phenyl, 1-3C alkyl (opt. substd. by phenyl) (where the phenyl gps. are opt. substd. by F, Cl, CF3, Me or OMe); Py = pyrrol-(1,2 or 3)-yl (opt. substd. by 1-4 of F, Cl, Br, I, CN, 2-8C alkanoyl, 2-8C alkoxycarbonyl, CHO, COOH, CF3, Me or OMe); m, h, l, d, r, p, q = 0-2; s is not defined; R14 = 3-8C cycloalkyl or phenyl(opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR15R16); Q = bond, O, S or NR18; Phe' = phenyl (substd. by (CH2)kCHR17COR20 and opt. substd. by one or 2 R'); R17 = OR21 or NR21R22; R20 = OR23 or NR23R24; R22 = H, 1-8C alkyl, 1-8C alkanoyl, 1-8C alkoxycarbonyl, benzyl or benzoyloxycarbonyl; R21 = as R22 or trityl; k, z = 1-4; R25 = 0-2C alkyl substd. by Het or its N-oxide; R26, R27 = H as for R25, H or 1-4C alkyl; T = as Q but not butylimino; i = 2-6; R31 = 1-8C alkyl, 3-6C alkenyl, (CH2)nR48 or CF3; R32,R34,R45 = H or as for R31; n, v = 0-4; R47 R69-R71 = H or 1-3C alkyl; R48 = 3-7C cycloalkyl or phenyl (opt. substd. by 1-3 or F, Cl, CF3, Me, OMe and NR49R50); R33, R46 = H or 1-4C alkyl; or R32+R33, R45+R46 = (CH2)5 or (CH2)6 (both opt. with one CH2 replaced by O, S, NH, NMe or N-benzyl); R51 = basic, protonisable residue ( i.e. NR52R53, C(=NR54)NR52R51 or NR55-C(=NR54)NR52R53) or a basic 1-9C heteroaryl ring; R52-R55 = H or 1-4C alkyl or R52+R53 = C4H8 or A1; or R53+R54, R54+R55 or R52+R55 = C2H4 or A2; A1 =C5H10, C6H12 or C7H14 (all with one C atom opt. replaced by O, SOd or NR56); A2 = C3H6, C4H8 or C5H10 (all with one C opt. replaced by O, SOd or NR56); A = CeH2e (opt. with one C replaced by O, CO, CH(OR57), SOr, NR57,CON(R57), SO2N(R57), NH-CO-NR57 or SO2NHCONR57); e = 0-10; G = phenylene (opt. substd. by one or two of Me, OMe, F, Cl, Br, I, CF3, SOsMe or SOsNR61R62; w = 0 or 1; E = O, CO, CH(OR63), S, SO, SO2, NH, or NMe; R64 = 1-4C alkyl or 3-7C cycloalkyl; R67, R68 = H or 1-6C alkyl; or R67+R68 = (CH2)4-7, opt. with one CH2 replaced by O, S, SO2, NH, NMe or N-benzyl; R4, R5 = H, 1-4C alkyl, F, Cl, OR69, NR70R71 or CzF2z+1; X = O or NR72; R6, R7, R9, R18, R49, R50, R61, R62, R65, R66, R72, R92-R95 = H or 1-4C alkyl; provided that R1-R7 and R72 are not all H.
-
公开(公告)号:SI9500282B
公开(公告)日:2001-12-31
申请号:SI9500282
申请日:1995-09-08
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER , LANG HANS-JOCHEN , SCHWARK JAN-ROBERT , WEICHERT ANDREAS , SCHOLZ WOLFGANG , ALBUS UDO
IPC: A61K31/165 , A61K31/155 , A61K31/18 , A61K31/27 , A61K31/275 , A61P3/08 , A61P3/10 , A61P3/12 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/00 , A61P25/02 , A61P25/28 , A61P35/00 , A61P41/00 , A61P43/00 , C07C229/00 , C07C277/08 , C07C279/22 , C07C317/46 , C07C323/44 , C07C323/60 , C07C323/63 , C07C229/36 , C07C317/24 , A61K31/19
Abstract: Benzoyl guanine derivs. of formula(I) and their salts are new. One of the substits. R1-R3 = Y-Ph-Ä(CH2)k-CHR7-CO-R8Ü; and the others = 1-8C alkyl, 2-8C alkenyl, (CH2)mR14, SO2NHC(=Y')NR18R19, H, halo, CN, Z(CH2)p-CqF2q+1, SOuR22, CONR23R24, COR25, SO2NR26R27, OR35 or NR35R36; Ph = phenylene (opt. mono- or di-substd. by Fl, Cl, CF3, Me, OH, OMe or NR37R38); R37, R38 = H or Me; Y = a bond, O, S or NR9; R9 = H or 1-4C alkyl; R7 = OR10 or NR10R11; R10 = H 1-8C alkyl, 1-8C alkanoyl, 1-8C alkoxycarbonyl, benzyl, or benzyloxycarbonyl; R11 = as R10 or trityl; R8 = OR12 or NR12R13; R12, R13 = H, 1-8C alkyl or benzyl; R14 = 3-8C cycloalkyl or phenyl (both opt. substd. by 1-3 F, Cl, CF3, Me, OMe, or NR15R16); R15, R16 = H or Me; Y' = O, S or NR20; R18, R19 = H, 1-8C alkyl, 3-6C alkenyl or (CH2)tR21; or R18+R19 = A; R21 = 5-7C cycloalkyl or phenyl, (both opt. mono- to tri-substd. by F, Cl, OMe or 1-4C alkyl); R20 = as R18 or amidine; Z = a bond, O, S or NR28; R22 = 1-8C alkyl, 3-6C alkenyl, (CH2)nR29 or CF3; R23, R25, R26 = as R22 or H; R24, R27 = H or 1-4C alkyl; or R23+R24, R26+R27 = A; A = (CH2)4 or (CH2)5 (both opt. having a CH2 replaced by O, S, NH, NMe or N-benzyl; R28 = H or 1-3C alkyl; R29 = 3-7C cycloalkyl or phenyl (both opt. substd. by 1-3 F, Cl, CF3, Me, OMe or NR30R31; R30, R31 = H or 1-4C alkyl; R35, R36 = H or 1-6C alkyl; or R35+R36 = (CH2)y (opt. having a CH2 gp. replaced by O, S, NH, NMe or N-benzyl); R4, R5 = H, 1-4C alkyl, F, Cl, OR32, NR33R34 or CrF2r+1; R32-R34 = H or 1-3C alkyl; k, n, t = 0-4; m, u, p = 0-2; q = 1-6; r = 1-4; and y = 4-7.
-
公开(公告)号:SI9500281B
公开(公告)日:2001-12-31
申请号:SI9500281
申请日:1995-09-08
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER , LANG HANS-JOCHEN , SCHWARK JAN-ROBERT , WEICHERT ANDREAS , SCHOLZ WOLFGANG , ALBUS UDO
IPC: A61K31/165 , A61K31/155 , A61K31/18 , A61K31/275 , A61P3/08 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P25/00 , A61P25/02 , A61P35/00 , A61P41/00 , A61P43/00 , C07C22/00 , C07C277/08 , C07C279/22 , C07C311/29 , C07C311/38 , C07C317/44 , C07C323/62 , C07C22/08 , C07C317/24
Abstract: Benzoylguanidines of formula (I) and their salts are new. R1 and R3 = H, halogen, CN, NO2, 1-8C alkyl, 3-8C cycloalkyl, Oa(CH2)b(CF2)cCF3, S(O)mR5, SO2NR6R7, SR11, OR11, CR11R12R13 or phenyl, naphthyl, biphenylyl or C- or N-bonded 1-9C heteroaryl gps. opt. substd. by 1-3 of F, Cl, CF3, Me, OMe, OH, NH2, NHMe and NMe2; a = 0 or 1; b = 0-2; c = 0-3; m = 0-2; R5 = 1-8C alkyl, 3-6C alkenyl, CF3 or CnH2n-R8; R6 = H, or as for R5; R7 = H or 1-4C alkyl; or R6+R7 = tetra- or pentamethylene, opt. with a CH2 gp. replaced by O, S, NH, NMe or NCH2Ph; n = 0-4; R8 = 3-7C cycloalkyl, or phenyl opt. substd. by 1-3 of F, Cl, CF3, Me, OMe and NR9R10; R9 and R10 = H or 1-4C alkyl; R11 = 3-8C cycloalkyl; (3-8C)cycloalkyl(1-2C)alkyl; or 1-9C heteroaryl or phenyl opt. substd. by 1-3 of F, Cl, CF3, OMe, OH, NH2, NHMe and NMe2; R12 and R13 = H, 1-4C alkyl or gps. as defined for R11; R2 = CF2R14, CF(R15)(R16), CF(Rf)-R15 or CRf=C(R15)(R16); R14 = 1-4C alkyl or 3-6C cycloalkyl; R15 and R16 = H or 1-4C alkyl; Rf = 1-3C perfluoro-n-alkyl; R4 = H, 1-3C alkyl, F, Cl, Br, I, CN or (CH2)s(CF2)tCF3; s = 0 or 1; t = 0-2.
-
-
-
-
-
-
-
-
-